Literature DB >> 10028520

Progress toward guidelines for the management of fatigue.

D Cella1, A Peterman, S Passik, P Jacobsen, W Breitbart.   

Abstract

Fatigue is a subjective state of overwhelming, sustained exhaustion and decreased capacity for physical and mental work that is not relieved by rest. Cancer-related fatigue has many causes. Included in the causes are the illness itself, the side effects of virtually every treatment, depression, and other biopsychosocial factors. As a result, fatigue is the most common symptom reported by cancer patients in most descriptive studies. In addition to arising from multiple etiologies, fatigue is also multidimensional in its manifestation and impact. Its effect on the quality of life of the patient is comparable to that of pain. Experienced by most patients as an extremely frustrating state of chronic energy depletion, it leads to loss of productivity which can reduce self-esteem. As a subtle and chronic symptom, it also places people at risk for being questioned about the veracity of their complaints, particularly during the post-treatment, disease-free survival period. Patients themselves are reluctant to complain of fatigue, perhaps because they believe little can be done about it, or they wish to avoid drawing attention away from treating their cancer.

Entities:  

Mesh:

Year:  1998        PMID: 10028520

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  95 in total

1.  Fatigue in cancer.

Authors:  G A Curt
Journal:  BMJ       Date:  2001-06-30

2.  Cancer fatigue--more data, less information?

Authors:  Susan B LeGrand
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

Review 3.  ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

Authors:  Andrea M Barsevick; Charles S Cleeland; Donald C Manning; Ann M O'Mara; Bryce B Reeve; Jane A Scott; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

4.  Further validation of the multidimensional fatigue symptom inventory-short form.

Authors:  Kevin D Stein; Paul B Jacobsen; Chris M Blanchard; Christina Thors
Journal:  J Pain Symptom Manage       Date:  2004-01       Impact factor: 3.612

5.  Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer.

Authors:  Nicholas Courtier; Tina Gambling; Stephanie Enright; Peter Barrett-Lee; Jacinta Abraham; Malcolm D Mason
Journal:  Support Care Cancer       Date:  2012-05-28       Impact factor: 3.603

Review 6.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

7.  A clinically translatable mouse model for chemotherapy-related fatigue.

Authors:  Jonathan A Zombeck; Edward G Fey; Gregory D Lyng; Stephen T Sonis
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

8.  Fatigue in a representative population of older persons and its association with functional impairment, functional limitation, and disability.

Authors:  Sonja Vestergaard; Susan G Nayfield; Kushang V Patel; Basil Eldadah; Matteo Cesari; Luigi Ferrucci; Graziano Ceresini; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-27       Impact factor: 6.053

9.  Recommendations for high-priority research on cancer-related fatigue in children and adults.

Authors:  Andrea M Barsevick; Michael R Irwin; Pamela Hinds; Andrew Miller; Ann Berger; Paul Jacobsen; Sonia Ancoli-Israel; Bryce B Reeve; Karen Mustian; Ann O'Mara; Jin-Shei Lai; Michael Fisch; David Cella
Journal:  J Natl Cancer Inst       Date:  2013-09-18       Impact factor: 13.506

10.  Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression.

Authors:  Siobhan M Phillips; Edward McAuley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.